Almirall Launches Act4Impact – its Updated Sustainability Strategy Setting Ambitious Targets for 2030

Contributed by: Business Wire

Logo

Images

Almirall photovoltaic installation in HQ Barcelona (Photo: Business Wire)

Business Wire embedded0

Tags

Other Health

General Health

Professional Services

Pharmaceutical

Environmental Health

Sustainability

Other Manufacturing

Environment

Biotechnology

Medical Supplies

Health

Environmental, Social and Governance (ESG)

Manufacturing

Act4Impact

More Like This

Almirall HQ in Barcelona (Photo: Business Wire)

Almirall at the JPMorgan Conference - Entering a New Era of Sustained Growth

Almirall’s 2025 9M Results

Almirall’s 2025 Results

Almirall HQ in Barcelona (Photo: Business Wire)

Almirall 2024 Full-Year Results: Almirall Surpassed Guidance for 2024 - Entering an Era of Sustained Growth and Further Advancing Its Medical Dermatology Pipeline

From left upper row, to right: Marc Soriano, R&D Project Portfolio and Partnership, Lidia Martín, General Manager of Almirall Iberia, Antonio Gallardo, Jorge Gallardo, Dr. Karl Ziegelbauer, Chief Scientific Officer of Almirall, Meritxell Granell, Director of Institutional Relations, Raquel Yotti, PERTE Commissioner for Vanguard Health, Olga Pané, Consellera de Salut, Lourdes Borrell, Mayoress of Sant Feliu de Llobregat, Salvador Illa, President of the Generalitat de Catalunya, Carlos Gallardo, CEO and President of Almirall, Juan Cruz Cigudosa, Secretary of State for Science, Innovation and Universities, Núria Montserrat, Consellera de Recerca i Universitats, and Jaume Baró, Secretary for Business and Competitiveness of the Department of Business and Employment. (Photo: Business Wire)

Almirall Launches The Hive, Creating a Novel Collaborative Innovation Hub to Advance Life Sciences and Healthcare

Almirall H1 2026 Results

Almirall H1 2025 Results

Almirall Presents R&D Pipeline Advances Supported by Sustained Growth and Leadership in Medical Dermatology at J.P. Morgan Healthcare Conference